TuisHIK • LON
add
Hikma Pharmaceuticals Plc
Vorige sluiting
GBX 1 660,00
Dagwisseling
GBX 1 626,00 - GBX 1 664,00
Jaarwisseling
GBX 1 626,00 - GBX 2 360,00
Markkapitalisasie
3,61 mjd GBP
Gemiddelde volume
751,52 k
P/V-verhouding
13,28
Dividend-opbrengs
3,91%
Primêre beurs
LON
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 829,00 m | 5,67% |
Bedryfskoste | 175,50 m | -0,85% |
Netto inkomste | 119,00 m | 5,31% |
Netto winsgrens | 14,35 | -0,35% |
Wins per aandeel | — | — |
EBITDA | 238,00 m | -4,61% |
Effektiewe belastingkoers | 18,64% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 236,00 m | -9,23% |
Totale bates | 5,55 mjd | 14,59% |
Totale aanspreeklikheid | 3,00 mjd | 17,90% |
Totale ekwiteit | 2,55 mjd | — |
Uitstaande aandele | 221,45 m | — |
Prys om te bespreek | 1,45 | — |
Opbrengs op bates | 8,42% | — |
Opbrengs op kapitaal | 11,38% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 119,00 m | 5,31% |
Kontant van bedrywe | 80,50 m | -18,69% |
Kontant van beleggings | -107,50 m | -102,83% |
Kontant van finansiering | 49,00 m | 288,46% |
Netto kontantverandering | 24,00 m | 54,84% |
Beskikbare kontantvloei | 79,88 m | -31,36% |
Meer oor
Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index. Wikipedia
Gestig
1978
Webwerf
Werknemers
9 500
